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Results: The median IgG4:IgG RNA ratio was significantly higher in the GPA cohort (5.7, IQR 2.6 -19.7) compared to all control groups: 1.2 in SLE (0.7 -3.3; p<0.01), 2.5 in RA (0.7 -4.1; p<0.05), 1.6 in PSC (1.0 -2.8; p<0.001) and 1.3 in HC (0.6 -1.8, p<0.01). In addition, the median IgG4:IgG RNA ratio was significantly higher in patients with active disease (23.8; IQR 12.1 -29.1) compared to patients in remission (3.5; IQR 2.0 -5.5) (p<0.0001). The height of the IgG4:IgG RNA ratio significantly correlated with height of the BVAS (r 2 =0.76, p<0.0001), while the ESR, CRP and ANCA titre did not. Interestingly, IgG4/IgG RNA ratios among patients with active disease were consistently above 9.3, and among patients in remission they were below this threshold.
Conclusions:
The IgG4:IgG RNA ratio distinguishes active GPA from GPA in remission with excellent specificity and sensitivity. Moreover the ratio shows a significant correlation with disease severity, in contrast to ESR, CRP and ANCA titre. Retesting in another, prospective study is indicated to validate the IgG4:IgG ratio as a novel, highly sensitive and specific marker of disease activity in GPA. Background: Retroperitoneal fibrosis (RPF) could be idiopathic or secondary to various factors including malignancy. Pathology remains the most reliable diagnostic approach. However, the pathological features have yet been well defined and the feasibility of biopsy procedure depends on several factors such as the proximity of the lesions to abdominal aorta.
18 F FDG-PET/CT may help exclude malignancy by assessing FDG-uptake and mapping the whole body, especially when biopsy procedure is inaccessible. Objectives: To evaluate the utility of PET/CT in distinguishing benign from malignant RPF. Methods: Patients with benign or malignant RPF diagnosed between September 2011 and June 2016 were included. Morphologic features, FDG-uptake of retroperitoneal lesions and lymph nodes (LNs) were compared. FDG-uptake of retroperitoneal lesions was assessed visually with the referrence of liver and assessed semiquantitatively with SUVmax. LNs were regarded as specific LNs if frequencies of LNs with high FDG-uptake were observed differently between two forms of RPF. ROC analyses were performed to evaluate the diagnostic accuracy. Results: Seventy-one cases with benign RPF and 21 cases with malignant RPF secondary to lymphoma (15) or metastatic carcinoma (6) with primary sites of pancreas (2), colon (2), stomach (1) and kidney (1) were included. The craniocaudal length, axial width, and distances between anterior or posterior 
